Search
Nanobiotix SA
NBTXAdd to Watchlist
39.480USD
+1.780+4.72%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.92BMarket Cap
LossP/E TTM
More Details of Nanobiotix SA Company
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Nanobiotix SA Info
Ticker SymbolNBTX
Company nameNanobiotix SA
IPO dateOct 29, 2012
CEOLevy (Laurent)
Number of employees108
Security typeDepository Receipt
Fiscal year-endOct 29
Address60 rue de Wattignies
CityPARIS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryFrance
Postal code75012
Phone33140260470
Websitehttps://www.nanobiotix.com
Ticker SymbolNBTX
IPO dateOct 29, 2012
CEOLevy (Laurent)
Company Executives of Nanobiotix SA
Name
Name/Position
Position
Shareholding
Change
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Anne-Sophie Lariviere
Ms. Anne-Sophie Lariviere
Vice President - Strategy & Operational Excellence
Vice President - Strategy & Operational Excellence
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
FAQs
Who are the top five shareholders of Nanobiotix SA?
The top five shareholders of Nanobiotix SA are: Dr. Laurent Levy, Ph.D.
How many institutions hold shares of Nanobiotix SA (NBTX)?
As of 2026Q1, 30 institutions hold shares of Nanobiotix SA, with a combined market value of approximately 5.71M, accounting for 11.79% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3044728.00.